Imprimis recalls Tri-Moxi+ eye injections due to glass particles. Stop using if you have the specific lot numbers listed. Contact for details.
Presence of particulate matter - Glass like particles.
Imprimis is recalling Tri-Moxi+ eye injections because they may contain glass particles. This could cause serious eye injury if injected. Affected products have specific lot numbers and expiration dates.
Glass particles in the injection could cause serious eye damage when injected into the eye. This is a risk during medical procedures requiring eye injections.
People who have received the recalled Tri-Moxi+ eye injections with lot numbers 25JAN033A or 25JAN033B. Those with the product are at highest risk of eye injury.
Check the lot number on the product label. The recalled items have lot numbers 25JAN033A or 25JAN033B and expire by February 12, 2026.
Immediately stop using the recalled Tri-Moxi+ eye injections if you have the specific lot numbers listed.
Imprimis recalls Tri-Moxi+ eye injections due to glass particles that could cause serious eye injury.
Lot numbers 25JAN033A and 25JAN033B.
Check the lot number on the product label; the recalled items have lot numbers 25JAN033A or 25JAN033B and expire by February 12, 2026.
We’ve drafted a message you can send Imprimis to request your refund or repair — edit it as you like.
Subject: Recall D-0251-2026 — Imprimis Imprimis Hello, I own a Imprimis that is covered by recall D-0251-2026 from Imprimis. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
